After ending the VX-264 trial, which used a device to protect lab-grown islet cells, the company will continue research on therapies with and without the need for immunosuppressive drugs. Vertex ...

Want to get to know some of the people making a difference in the diabetes world? In our “5 Minutes With” series, we talk to experts and advocates who share inspiring stories and their take on the ...